Illumisonics
IllumiSonics Inc. is a biomedical technology company focused on transforming tissue imaging with its proprietary MLI™ (Multi-Laser Imaging) technology. This advanced optical imaging system offers a non-contact, label-free approach to capture deep data within tissues. Their primary product, the MLI Advanced Imaging Device (AID), is designed for life sciences and digital pathology, enabling multiple analyses on a single fresh tissue sample without chemical stains. This technology supports AI-assisted diagnostics through multiplexed virtual staining and native molecular visualization, with applications extending to cancer diagnosis, drug development, and various fields including ophthalmology, agriculture, and material science. The company has received recognition, including an INOVAIT Focus Fund investment and a patent for its PARS® technology.
Illumisonics
IllumiSonics Inc. is a biomedical technology company focused on transforming tissue imaging with its proprietary MLI™ (Multi-Laser Imaging) technology. This advanced optical imaging system offers a non-contact, label-free approach to capture deep data within tissues. Their primary product, the MLI Advanced Imaging Device (AID), is designed for life sciences and digital pathology, enabling multiple analyses on a single fresh tissue sample without chemical stains. This technology supports AI-assisted diagnostics through multiplexed virtual staining and native molecular visualization, with applications extending to cancer diagnosis, drug development, and various fields including ophthalmology, agriculture, and material science. The company has received recognition, including an INOVAIT Focus Fund investment and a patent for its PARS® technology.